We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04634825
Brief Title: Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer

First Submitted : November 12, 2020
First Submitted that Met QC Criteria : November 12, 2020
First Posted : November 18, 2020

Last Update Submitted that Met QC Criteria : November 2, 2022
Last Update Posted : November 7, 2022